Loading clinical trials...
Loading clinical trials...
Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Conditions
Interventions
EG-1962 (nimodipine microparticles)
Enteral Nimodipine
Locations
4
United States
Dignity Health; St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States
University of California San Francisco
San Francisco, California, United States
University of Maryland Medical Systems
Baltimore, Maryland, United States
University of Alberta Hospital/Mackenzie Health Sciences Centre
Edmonton, Alberta, Canada
Start Date
September 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
March 1, 2018
Last Updated
July 26, 2018
NCT06119061
NCT06766422
NCT05103566
NCT05604404
NCT04490161
NCT06436508
Lead Sponsor
Edge Therapeutics Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions